Abstract
Apolipoprotein B (apoB) levels predict fatal myocardial infarction. Whether apoB also predicts nonfatal ischemic cardiovascular events is unclear. We tested the following hypotheses: apoB predicts ischemic cardiovascular events, and apoB is a better predictor of ischemic cardiovascular events than low-density lipoprotein cholesterol.
| Original language | English |
|---|---|
| Journal | Arteriosclerosis, Thrombosis, and Vascular Biology |
| Volume | 27 |
| Issue number | 3 |
| Pages (from-to) | 661-70 |
| Number of pages | 10 |
| ISSN | 1079-5642 |
| DOIs | |
| Publication status | Published - 2007 |
Keywords
- Adult
- Age Distribution
- Aged
- Aged, 80 and over
- Apolipoproteins B
- Biological Markers
- Cholesterol, LDL
- Cohort Studies
- Female
- Humans
- Incidence
- Ischemic Attack, Transient
- Male
- Middle Aged
- Myocardial Infarction
- Myocardial Ischemia
- Predictive Value of Tests
- Prognosis
- Proportional Hazards Models
- Risk Assessment
- Sensitivity and Specificity
- Severity of Illness Index
- Sex Distribution
- Stroke
Fingerprint
Dive into the research topics of 'Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS